Field Procedures: What to Do Before, During, and After a Home Emergency

Before the visit (pre-checks and environment). Every home visit begins with a short “go/no-go” checklist: identity verified; consent current; contraindications reviewed; emergency contacts and local EMS address confirmed; kit inventory checked (PPE, sharps, spill kit, anaphylaxis card, bandages); and a quick environmental scan (trip hazards, pets, ventilation, privacy). If conditions are unsuitable—no safe surface for phlebotomy, violent household member present—staff activate a “deferral” code, document the reason, and reschedule or reroute to a clinic partner. Pre-visit screening includes recent fevers, new medications, and allergies. For investigational product (IP) administration at home, confirm storage conditions and seal integrity before proceeding.

During the visit (conduct and immediate response). Mobile clinicians follow task-based, icon-driven job aids that double as source worksheets. Examples: venipuncture steps; ECG patch placement; home spirometry positioning; IM or SC administration; and device pairing. For common critical events, scripts are explicit and short:

• Syncope/fall: protect the head, assess airway/breathing/circulation (ABCs), elevate legs if appropriate, check glucose if indicated, call the 24/7 line, consider EMS; document vitals every 5 minutes and any head strike.
• Anaphylaxis: recognize rapid onset with airway/respiratory/skin symptoms; activate EMS immediately; administer epinephrine if permitted by protocol and scope; place participant supine with legs elevated (unless breathing worsens); record lot/expiry of any rescue medication and time of administration.
• Bleeding/hematoma: apply direct pressure; for arterial spurting, pressure + tourniquet per training; escalate if not controlled within 10 minutes; document site and estimated blood loss.
• Device reaction or detachment: remove device if protocol allows; photograph site (with consent), capture device serial/UDI; replace or suspend per job aid; open an event in the evidence hub.

Ambulance handoff packet. Each kit includes a one-page handoff: participant initials/ID, study name, PI phone, medical history snapshot, current medications, last dose/time, investigational product class and key risks, allergy list, and “do not disclose allocation” note for blinded studies. The mobile clinician (or call center) relays the packet verbally and electronically to receiving EMS/ED where possible.

After the event (documentation and follow-through). Within the same day: capture a brief narrative (who/what/when/where/why), vitals, photos of relevant artifacts (seal IDs, temperature loggers, device labels), and all phone/video contacts. The system prompts for causality, expectedness, and seriousness assessments by the investigator or safety physician. If treatment assignment is required for medical management, a closed, unblinded unit performs the minimal unblinding and records rationale and scope. Follow-up tasks include participant check-ins, resupply of used kit components, and updates to re-consent status if risk information changed.

For remote-only encounters. When no clinician is physically present, tele-triage follows the same ABC logic with step-down modes (video → audio + photos → SMS). The platform documents which mode was used and why; calls are time-stamped, and “unable to connect” results open escalation tasks. If the participant is alone and symptomatic, staff call local EMS while staying on the line and contact the PI.

The Evidence System Behind Safety: 24/7 Coverage, Alerts, Unblinding, and Privacy

24/7 clinical coverage that actually covers. Participants receive one number (and an in-app tile) that routes to an on-call research clinician within minutes. The schedule shows who is primary and secondary; handovers include a “hot list” of participants at higher risk (recent dose, device change, prior reaction). Calls open cases automatically in the evidence hub with local and UTC timestamps and identities for all parties present (participant, caregiver, interpreter).

Sensor-driven and logistics-driven alerts. For studies using wearables or connected devices, predeclare alert thresholds (e.g., sustained bradycardia, precipitous SpO₂ drop, hypoglycemia episodes) and specify who receives them, within what time, and what actions follow. For direct-to-patient shipping, red temperature logs automatically quarantine product and generate a clinical check on exposure/interruption. Every alert is version-locked with thresholds, persistence, and actions; changes require impact analysis and dated approvals.

Expectedness, causality, and minimal-disclosure unblinding. The Safety Management Plan defines sources used for expectedness (IB/IMPD, class effects, known device reactions) and the causality framework. If medical management requires knowing allocation, unblinding happens within a closed unit that records “who learned what and why” and the exact data disclosed. Scripts, screens, and emails used by blinded teams remain “arm-silent.”

Timelines and reconciliation. AE/SAE capture prompts include clock-aware deadlines for regulatory and ethics reporting, with task owners and due dates. Nightly, the safety database reconciles with eSource (symptoms, vitals, procedures), IRT (dosing and shipment events), and sensor hubs (alert streams). Any gaps open tasks that cannot be closed without a reason code. For adjudicated endpoints (e.g., MACE), source packets are assembled with redaction rules and a provenance manifest.

ALCOA++ documentation without screenshots. All safety artifacts live in systems of record with deep links between them—no ad-hoc file copies. Case narratives carry identity-bound signatures; photographs are watermarked and time-stamped; device/browser metadata are captured for tele-visits; and sealed data cuts store inputs, transforms, and environment hashes. Before first patient, before interim, and before submission, teams rehearse five-minute retrieval drills that start from a CSR table and end at the originating artifact.

Privacy by design in a crisis. Emergencies should not justify over-collection. Use the minimum necessary data for clinical care, separate unblinded repositories, tokenize identifiers on ingress, and keep re-identification keys under dual control with immutable logs. Subject-level exports are denied by default and watermarked when authorized. If photographs are required (e.g., injection site, device rash), mask bystanders and ambient identifiers.

Training that sticks. Scenario-based micro-lessons—60–90 seconds on epinephrine steps, syncope posture, red-logger rules, or minimal-disclosure language—are embedded inside the tools. Staff record “I applied this” attestations for high-risk steps. Participants receive short, language-appropriate guides and a laminated escalation card. The goal is confidence under stress, not long webinars.

Governance, KRIs/QTLs, 30–60–90 Plan, Pitfalls, and a Ready-to-Use Checklist

Dashboards that click to proof. Oversight teams monitor leading signals and can drill from the number to the artifact without exports. Minimum tiles include: time-to-answer for the 24/7 line; EMS referrals; red-logger events and product quarantines; sensor alert counts and closure times; audio-only reliance where video was expected; missed window due to safety holds; unblinding events; reconciliation gaps; and five-minute retrieval pass rate. Each tile links to the case, temperature file, pairing log, or safety narrative.

Key Risk Indicators (KRIs) and Quality Tolerance Limits (QTLs). Examples of KRIs: first-contact delays >5 minutes at night; repeated device reactions; shipping excursions with delayed clinical follow-up; alert backlogs >24 hours; and incomplete narratives. Candidate QTLs include: “≥5% of safety calls answered after 5 minutes,” “≥10% of red-logger events unresolved within 24 hours,” “sensor alert backlog >10% of active alerts,” “≥2% of source corrections without rationale,” “≥1 unblinding event without documented rationale,” or “retrieval pass rate <95%.” Crossing a limit triggers containment (pause shipments on failing lanes, add staff to coverage, suppress a firmware channel), a dated corrective plan, and named owners.

30–60–90-day implementation plan. Days 1–30: write the safety management plan; define at-home procedures allowed and those that must stay in clinic; select the 24/7 triage vendor and escalation tree; standardize the ambulance handoff packet; finalize emergency kit contents by country; draft job aids; and run tabletop drills (syncope, anaphylaxis, red logger, device rash, audio-only fallback). Days 31–60: validate tele-triage, eSource, safety database, and IRT integrations; configure alert thresholds; release translated participant materials; train staff with scenario drills; stand up dashboards, KRIs, and QTLs; and rehearse five-minute retrieval from a CSR table to the artifact. Days 61–90: soft-launch in limited regions; monitor KRIs; tune materials and kit contents; refine unblinding scripts; file “what changed and why” notes; institutionalize monthly retrieval drills and quarterly incident tabletops; and scale globally with country-specific emergency numbers and kit variants.

Common pitfalls—and durable fixes.

• Confusing logistics incidents with clinical ones. Fix with red-logger rules: quarantine first, clinical check next, reship quickly; track closure time.
• Over-reliance on video. Fix with audio-first protocols, SMS/photo workflows, and explicit endpoint allowances.
• Arm leakage during emergencies. Fix with arm-silent scripts, closed safety units for unblinding, and strict recording of “who learned what and why.”
• Shadow records. Fix with deep links among systems of record and sealed data cuts; retire screenshots and email trails.
• Training theater. Fix with in-tool micro-lessons tied to high-risk steps and “I applied this” attestations.
• Equity blind spots. Fix with interpreter pathways, local EMS mapping, device loans, and after-hours options.

Inspection-ready safety checklist (paste into your SOP or study-start plan).

• Safety Management Plan finalized: at-home procedures, escalation tree, alert thresholds, expectedness/causality, minimal-disclosure unblinding.
• 24/7 triage line active with coverage rosters; time-to-answer monitored; ambulance handoff packet standardized and loaded in kits.
• Home visit go/no-go, emergency kit BOM, and country-specific emergency numbers released and version-locked.
• Tele-triage, eSource, safety DB, and IRT integrations validated; deep links replace file copies; ALCOA++ enforced.
• Red-logger workflow: automatic quarantine, clinical check, reship; closure times tracked; chain-of-custody recorded.
• Sensor alerts validated; thresholds and actions version-locked; backlogs monitored and cleared within SLAs.
• Blinding protection: arm-silent scripts; closed safety unit; rationale logged for any unblinding.
• Participant materials: plain-language, large-font, icon-driven, translated; interpreter and audio-first options documented.
• KRIs/QTLs live (time-to-answer, red-logger closure, alert backlog, reconciliation gaps, retrieval rate); containment playbooks rehearsed.
• Five-minute retrieval drills ≥95% pass; “what changed and why” notes filed for each system and content release.

Bottom line. Safety in decentralized trials is not about improvisation at a doorstep; it is about engineering a small, disciplined system that performs under stress. When triage is reachable in minutes, scripts are clear, kits are complete, alerts are predeclared, unblinding is controlled, and every number clicks to proof, participants are protected and programs are inspection-ready—no matter where care happens.